(Q37761937)

22 August 2017

title

Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region (English)

1 reference

22 August 2017

0 references

0 references

1 reference

S Bohlega

1

1 reference

22 August 2017

T Alsaadi

2

1 reference

22 August 2017

A Amir

3

1 reference

22 August 2017

H Hosny

4

1 reference

22 August 2017

A M Karawagh

5

1 reference

22 August 2017

D Moulin

6

1 reference

22 August 2017

N Riachi

7

1 reference

22 August 2017

A Salti

8

1 reference

22 August 2017

S Shelbaya

9

1 reference

22 August 2017

publication date

1 March 2010

1 reference

Journal of International Medical Research

22 August 2017

published in

1 reference

22 August 2017

volume

38

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

295-317

1 reference

Neuropathic pain: redefinition and a grading system for clinical and research purposes

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Diagnosis and management of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Opioids for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Tramadol for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Treatment of neuropathic pain: an overview of recent guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Guidelines for the diagnosis and management of neuropathic pain: consensus of a group of Latin American experts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

The unequal burden of pain: confronting racial and ethnic disparities in pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

The burden and costs of chronic diseases in low-income and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Contemporary management of neuropathic pain for the primary care physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Persistent pain and well-being: a World Health Organization Study in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Paper versus electronic rating scales for pain assessment: a prospective, randomised, cross-over validation study with 200 chronic pain patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Metabolic syndrome prevalence, dietary intake, and cardiovascular risk profile among overweight and obese adults 18-50 years old from the United Arab Emirates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Cross-national epidemiology of major depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Pregabalin: in the treatment of painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

The impact of neuropathic pain on health-related quality of life: review and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Metabolism of tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Drug-induced cognitive impairment in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Clinically significant drug interactions with antidepressants in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Safety of antidepressants in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Use of selective serotonin reuptake inhibitors in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

A review of central neuropathic pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Pregabalin in the management of central neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Oral opioid therapy for chronic peripheral and central neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

Clinical pharmacokinetics of pregabalin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800201

10.1177/147323001003800201

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference